Patent 9890410 was granted and assigned to Momenta Pharmaceuticals on February, 2018 by the United States Patent and Trademark Office.
The present invention provides methods of evaluating a glycoprotein preparation for the absence, presence or amount of an N-acetylhexosamine glycan, e.g., an N-acetylglucosamine glycan.